XML 21 R3.htm IDEA: XBRL DOCUMENT v3.24.2Close
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Net sales $ 1,841,430 $ 2,207,118 $ 5,550,823 $ 6,883,029
Cost of sales 1,687,891 2,023,910 5,081,687 6,313,246
Gross profit 153,539 183,208 469,136 569,783 Close
Operating expenses:        
Selling, general and administrative 61,720 68,828 195,704 192,948
Research and development 7,659 6,719 20,271 18,712
Restructuring 1,793 296 7,257 1,731
Total operating expenses 71,172 75,843 223,232 213,391 Close
Operating income 82,367 107,365 245,904 356,392 Close
Interest income 2,572 4,213 9,641 9,685 Close
Interest Expense, Nonoperating 7,506 10,066 24,136 28,033 Close
Other expense (2,795) (2,508) (652) (11,988) CloseClose
Interest and other, net (7,729) (8,361) (15,147) (30,336) Close
Total Other Income Expenses -446.0 3410.0 17978.0 -4606.0 0.0 Close
Income before income taxes 74,638 99,004 230,757 326,056 CloseClose
Provision for income taxes 19,900 17,267 60,346 63,898 Close
Net income before noncontrolling interest 54,738 81,737 170,411 262,158 Close
Less: Net income attributable to noncontrolling interest 3,136 5,243 9,256 14,029
Net income attributable to common shareholders $ 51,602 $ 76,494 $ 161,155 $ 248,129
Net income attributable to common shareholders per share:        
Basic $ 0.93 $ 1.32 $ 2.88 $ 4.28
Diluted $ 0.91 $ 1.28 $ 2.82 $ 4.14
Weighted-average shares used in computing per share amounts:        
Basic 55,466 57,987 55,862 57,995
Diluted 56,711 59,592 57,216 59,996